Airsculpt Technologies, Inc. key statistics and ratios

In fiscal 2025, Airsculpt Technologies, Inc. had return on equity of -14.1%, an operating margin of -7.6%, debt equal to 64.9% of equity and a current ratio of 0.55. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Airsculpt Technologies, Inc.: financial ratios, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Operating margin	1.6%	16.0%	11.8%	−2.7%	5.0%	−0.9%	−7.6%	−8.4%
Net margin	−5.4%	12.1%	7.9%	−8.7%	−2.2%	−4.4%	−7.7%	−7.8%
Free-cash-flow margin	1.2%	16.4%	14.6%	6.8%	7.2%	−1.5%	0.5%	0.5%
Return on equity	—	—	12.6%	−19.0%	−5.5%	−10.0%	−14.1%	−12.2%
Return on assets	—	4.2%	5.6%	−7.3%	−2.1%	−3.8%	−5.8%	−6.2%
Asset turnover	—	0.35	0.70	0.84	0.97	0.87	0.76	0.79
Current ratio	—	1.22	1.79	0.75	0.79	0.59	0.55	0.79
Debt to equity	—	—	100.9%	120.1%	88.2%	90.5%	64.9%	42.2%
Interest cover (operating income ÷ interest)	0.2x	4.1x	3.2x	n/m	1.5x	n/m	n/m	n/m
Effective tax rate	—	0.0%	3.0%	—	—	—	—	—
SG&A as % of revenue	48.8%	37.6%	49.3%	60.1%	52.3%	54.8%	54.1%	55.6%
Capital spending as % of revenue	10.8%	5.9%	5.3%	7.7%	5.1%	7.8%	1.6%	0.3%
Free cash flow ÷ net income	—	135.5%	185.0%	—	—	—	—	—
Dividends ÷ net income	—	0.0%	0.0%	—	—	—	—	—
Dividends and buybacks ÷ free cash flow	—	0.0%	0.0%	200.9%	2.7%	—	0.0%	—

US$ thousands unless shown otherwise. Fiscal quarters.

Airsculpt Technologies, Inc.: financial ratios, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Operating margin	−8.7%	−9.9%	−4.0%	1.8%	−27.9%	−3.0%	−4.6%	−0.1%
Net margin	−14.2%	−12.3%	−7.2%	−1.3%	−27.2%	3.8%	−6.1%	−2.6%
Free-cash-flow margin	−7.2%	−2.1%	−2.6%	10.7%	−1.2%	−7.7%	13.3%	−3.4%
Current ratio	0.51	0.59	0.57	0.64	0.51	0.55	0.75	0.79
Debt to equity	85.0%	89.2%	89.9%	64.1%	69.3%	63.9%	44.7%	41.6%
SG&A as % of revenue	59.9%	59.6%	55.3%	51.5%	55.8%	54.5%	57.3%	54.6%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 7 checks passed · June 30, 2026

What it owns · $193m

Short-term assets $27mLonger-term assets $166m

What it owes, and who funded it · $193m

Short-term liabilities $35mLonger-term liabilities $54mShareholders' equity $105m

Short-term assets cover short-term liabilities $27m of assets due within a year against $35m of liabilities due within a year.
Short-term assets cover long-term liabilities $27m short-term assets against $54m of longer-dated liabilities.
More cash than debt $19m of cash against $44m of debt.
Debt below 40% of shareholders' equity Debt is 42% of equity.
Debt burden no higher than five years ago Debt to equity moved from 98% to 42% over five years.
A year's operating cash flow covers at least 20% of debt $1m of operating cash flow against $44m of debt.
Operating profit covers interest at least five times over Operating income of −$13m against $5m of interest.

From Airsculpt Technologies, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: AIRS vs NRC AIRS vs PETS AIRS vs RDGT AIRS vs SBC

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Airsculpt Technologies, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Airsculpt Technologies, Inc.